CHIME launches info security organization

The College of Healthcare Information Management Executives has launched a new organization to serve the education and professional development needs of healthcare executives in senior information security roles.

The Association for Executives in Healthcare Information Security (AEHIS) will provide educational resources on healthcare security issues and "an environment where CSOs can communicate with, inform and educate one another," according to a release.

"As patient data breaches and cyber security threats continue to rise, there has never been a greater need for accomplished and skilled professionals to safeguard our industry's most sensitive information," said CHIME President and CEO Russell P. Branzell, CHCIO. "The CHIME board recognized our industry's void in supporting the professional development and peer-to-peer needs of CSOs, and that educational resources for key members of the CIO's executive team were lacking."

"We are pleased to be able to assist in the establishment of this important new organization," said CHIME Board Chair Randy McCleese, LCHIME, CHCIO. "With hundreds of data breaches being reported, and a shortage of security professionals with a background in healthcare, it has become increasing clear that this group could greatly benefit from the kind of opportunities that CHIME provides CIOs."

AEHIS will operate as a separate membership association under the umbrella of CHIME. Interested CSOs that apply and are accepted before December 31 will be recognized as AEHIS founding members and will receive a one-year complimentary membership.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.